FLAVONE ACETIC-ACID AND PLASMA-PROTEIN BINDING

被引:7
作者
BRODFUEHRER, J
VALERIOTE, F
CHAN, K
HEILBRUN, L
CORBETT, T
机构
[1] Division of Hematology and Oncology, Department of Internal Medical, Wayne State University, Detroit, 48 202, MI
关键词
D O I
10.1007/BF00689272
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Both the capacity of healthy human, cancer patient, and mouse plasma proteins to bind flavone acetic acid (FAA) and the qualitative differences in the plasma protein-binding site were studied. The binding capacity of plasma proteins for FAA was saturated within the therapeutic range in both species. The binding of FAA to plasma protein was significantly greater in both healthy human and cancer patient plasma than in mouse plasma. Plasma from patients with cancer bound on the average less FAA than did healthy patient plasma. The concentration of albumin in the plasma varied between healthy humans, cancer patients, and mice, being 5.3±0.7, 4.7±0.8, and 3.9±0.3 g/100 ml, respectively. The protein binding of FAA was found to be dependent on the plasma albumin concentration, but albumin concentration alone was not adequate for the accurate prediction of the percentage of FAA protein bound. Scatchard plots indicated that healthy human plasma had a greater number of high-affinity binding sites than did mouse plasma. FAA binds at the indolebenzodiazepine binding area on albumin and can be displaced from this site by salicylic acid and clofibric acid, but only at supratherapeutic concentrations. Our results indicate that alterations in plasma albumin could contribute to a variable effect with FAA. Therefore, the influence of serum albumin concentration and the nonlinearity of FAA protein binding should be considered in assessment of the appropriateness of a dose schedule for FAA. © 1990 Springer-Verlag.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 50 条
[41]   ENHANCEMENT OF CHLORAMBUCIL CYTOTOXICITY BY COMBINATION WITH FLAVONE ACETIC-ACID IN A MURINE TUMOR [J].
PARKINS, CS ;
CHADWICK, JA ;
CHAPLIN, DJ .
ANTICANCER RESEARCH, 1994, 14 (4A) :1603-1608
[42]   IDENTIFICATION AND CHARACTERIZATION OF THE MAJOR HUMAN METABOLITES OF FLAVONE ACETIC-ACID (FAA) [J].
CUMMINGS, J ;
SMYTH, JF ;
DOUBLE, JA ;
FARMER, P ;
KAYE, SB .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 :486-486
[43]   FLAVONE ACETIC-ACID AND 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID - RELATIONSHIP BETWEEN PLASMA NITRATE ELEVATION AND THE INDUCTION OF TUMOR NECROSIS [J].
VESZELOVSZKY, E ;
THOMSEN, LL ;
ZHUANG, L ;
BAGULEY, BC .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (03) :404-408
[44]   THE PLASMA-PROTEIN BINDING OF HIDA [J].
NICHOLSON, RW ;
HERMAN, KJ ;
SHIELDS, RA ;
TESTA, HJ .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1980, 5 (04) :311-312
[45]   PLASMA-PROTEIN BINDING OF FENTANYL [J].
BOWER, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (08) :507-514
[46]   PLASMA-PROTEIN BINDING OF CARBAMAZEPINE [J].
HOOPER, WD ;
DUBETZ, DK ;
BOCHNER, F ;
COTTER, LM ;
SMITH, GA ;
EADIE, MJ ;
TYRER, JH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (04) :433-440
[47]   PLASMA-PROTEIN BINDING OF PHENCYCLIDINE [J].
GILES, HG ;
MILLER, RB ;
KHOUW, V ;
JUZYTSCH, W ;
SELLERS, EM .
FEDERATION PROCEEDINGS, 1981, 40 (03) :318-318
[48]   PLASMA-PROTEIN BINDING OF CEFTRIAXONE [J].
POPICK, AC ;
CROUTHAMEL, WG ;
BEKERSKY, I .
XENOBIOTICA, 1987, 17 (10) :1139-1145
[49]   PLASMA-PROTEIN BINDING OF EPINEPHRINE [J].
RUSSELL, JC ;
DOTY, DM .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 :1414-&
[50]   PLASMA-PROTEIN BINDING OF BEPRIDIL [J].
PRITCHARD, JF ;
MCKOWN, LA ;
DVORCHIK, BH ;
ONEILL, PJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (05) :347-353